Gene · 34
Papers1,869
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,869
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma. | Molecules | 2021 | 34885651 | PubTator, text mining | PubMed |
| Effect of 2-Cys Peroxiredoxins Inhibition on Redox Modifications of Bull Sperm Proteins. | Int J Mol Sci | 2021 | 34884692 | PubTator, text mining | PubMed |
| Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients. | Front Immunol | 2021 | 34867990 | PubTator, text mining | PubMed |
| Genome-wide differential expression profiling of lncRNAs and mRNAs in human induced pluripotent stem cell-derived endothelial cells exposed to e-cigarette extract. | Stem Cell Res Ther | 2021 | 34863290 | PubTator, text mining | PubMed |
| Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence. | Sci Rep | 2021 | 34848761 | PubTator, text mining | PubMed |
| 12th ISNS European Regional Meeting Oral and Poster Abstracts. | Int J Neonatal Screen | 2021 | 34842605 | PubTator, text mining | PubMed |
| Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? | Mol Biomed | 2021 | 34841263 | PubTator, text mining | PubMed |
| Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. | Cells | 2021 | 34831201 | PubTator, text mining | PubMed |
| Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis. | Cancer Manag Res | 2021 | 34824550 | PubTator, text mining | PubMed |
| Clinical Significance of Screening Differential Metabolites in Ovarian Cancer Tissue and Ascites by LC/MS. | Front Pharmacol | 2021 | 34795577 | PubTator, text mining | PubMed |
| SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence. | J Diabetes Res | 2021 | 34790827 | PubTator, text mining | PubMed |
| Status epilepticus and coma leading to death in a boy caused by Medium-chainacyl-coA dehydrogenase deficiency. | Iran J Child Neurol | 2021 | 34782845 | PubTator, text mining | PubMed |
| Lipid Catabolism and ROS in Cancer: A Bidirectional Liaison. | Cancers (Basel) | 2021 | 34771647 | PubTator, text mining | PubMed |
| Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases. | J Clin Med | 2021 | 34768374 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Acetyl-CoA derived from hepatic mitochondrial fatty acid β-oxidation aggravates inflammation by enhancing p65 acetylation. | iScience | 2021 | 34746707 | PubTator, text mining | PubMed |
| Exploring the Molecular Mechanism of Action of Yinchen Wuling Powder for the Treatment of Hyperlipidemia, Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation. | Biomed Res Int | 2021 | 34746316 | PubTator, text mining | PubMed |
| Evaluation of the Molecular Mechanisms of Sepsis Using Proteomics. | Front Immunol | 2021 | 34745104 | PubTator, text mining | PubMed |
| Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level. | Cell Death Dis | 2021 | 34741022 | PubTator, text mining | PubMed |
| Bioinformatics analysis reveals the roles of cytoskeleton protein transgelin in occurrence and development of proteinuria. | Transl Pediatr | 2021 | 34733666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/34/papers?page=25